Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities
- 1 July 2010
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 638 (1-3) , 108-114
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and PathophysiologyAntioxidants & Redox Signaling, 2009
- Reactive oxygen species and the control of vascular functionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Catalase and glutathione peroxidase mimicsBiochemical Pharmacology, 2009
- Bcr Kinase Activation by Angiotensin II Inhibits Peroxisome Proliferator-Activated Receptor γ Transcriptional Activity in Vascular Smooth Muscle CellsCirculation Research, 2009
- Redox Control of Renal Function and HypertensionAntioxidants & Redox Signaling, 2008
- Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-γ-modulating activity, on nitric oxide bioavailability and atherosclerotic changeJournal Of Hypertension, 2008
- Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2-Angiotensin-(1-7)-Mas Receptor AxisHypertension, 2007
- Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevanceAmerican Journal of Physiology-Renal Physiology, 2007
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006
- NADPH oxidase inhibitor, apocynin, restores the impaired endothelial‐dependent and ‐independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunctionDiabetes, Obesity and Metabolism, 2004